CAS: 3739-94-4; 2,6-Pyridinedicarboxylicacidchloride

相似化合物

137178-88-2 5431-44-7 311767-65-4

上下游产品

CAS号499-83-2 2,6-吡啶二羧酸 | CAS号108-48-5 2,6-二甲基吡啶 | CAS号7170-36-7 2,6-吡啶二羧酸单甲酯 | CAS号109452-64-4 2-N,2-N,6-N,6-N... | CAS号5431-44-7 2,6-吡啶二甲醛 | CAS号39977-44-1 6-羟甲基吡啶-2-羧酸甲酯 | CAS号41337-81-9 6-羟基甲基-吡啶-2-羧酸乙酯 | CAS号4663-97-2 2,6-吡啶二甲酰胺 | CAS号174500-20-0 2,6-双[|4S|-4-苯基... | CAS号223130-58-3 2-N,6-N-bis(2-s... | CAS号183618-15-7 2-N,6-N-bis(1-m... | CAS号1197-10-0 6-羧基吡啶-2-甲醇 | CAS号33858-36-5 2,6-双(苯并[d]恶唑-2-基)吡啶

2,6-二甲基吡啶置于potassium Permanganate,氯化亚砜体系中,化学反应生成2,6-氯甲酰吡啶
参考文献:螯合双(亚氨基)吡啶钴配合物:Li+阳离子活化生成乙烯聚合催化剂的合成,还原和证据
标题:螯合双(亚氨基)吡啶钴配合物:Li+阳离子活化生成乙烯聚合催化剂的合成,还原和证据
摘要:用fecl 2 或cocl 2 处理双(亚氨基苄基)吡啶螯合席夫碱配体8 (Ligph) 产生相应的(Ligph) Mcl 2 配合物9 (Fe)和10 (Co).10与甲基锂或"丁二烯-镁"的反应导致还原得到相应的(Ligph)Co(I)Cl产物11.类似地,双(芳基亚氨基乙基)吡啶配体(Ligme)与cocl2反应得到(Ligme) )Cocl2 (12).通过用"丁二烯-镁"处理来还原成(Ligme)Cocl (13).配合物 13 在甲苯中与 Li[b(C6F5)4] 反应,然后用吡啶处理,得到 [(Ligme)Co+-吡啶] (15).Co(II) 络合物 10 或 12 与约 3 摩尔当量的甲基锂分别得到钴 (I) 配合物 16 和 17.用li[b(C6F5)4]处理(Ligme)Coch3(17)得到低活性的乙烯聚合催化剂.同样,在用化学计量量的 Li[b(C6F5)4 处理后,复合物
Doi:10.1021/ja052129K

专利信息

专利号:US-6861531-B2
优先权日:2002-03-27
标 题:Synthesis of 2,6-dicarbonylpyridines
发明人：GATELY DANIEL A
权利人:BOULDER SCIENT CO
摘要:Synthesis of 2,6-dicarbonylpyridines in solution in a hydrocarbon medium is described. The solutions of 2,6-dicarbonylpyridines may be used directly in further syntheses.

专利号:US-2005239808-A1
优先权日:2002-05-10
标题 :Active substances for the treatment, diagnosis and prophylaxis of diseases in which abnormal protein structures occur
发明人：SCHRADER THOMAS; RIESNER DETLEV; RZEPECKI PETRA; NAGEL-STEGER LUITGARD; WEHNER MARK; KIRSTEN CHRISTIAN; MOLT OLIVER; ZADMARD REZA; ASCHERMANN KATJA
权利人:SCHRADER THOMAS; RIESNER DETLEV; RZEPECKI PETRA; NAGEL-STEGER LUITGARD; WEHNER MARK; KIRSTEN CHRISTIAN; MOLT OLIVER; ZADMARD REZA; ASCHERMANN KATJA
摘要:The invention on hand refers to diseases associated with abnormal protein structures, including Alzheimer's disease, Creutzfeldt-Jakob's disease, BSE and other prion-associated diseases. It is the task of the invention on hand to provide new active agents preventing the formation of amyloid plaques and to dissolve existing plaques, such agents being convenient for therapy, diagnosis and prophylaxis of diseases that are associated with abnormal protein structures. This task is performed in terms of the current invention by heterocyclic or aromatic agents with a rigid structure and a donor-acceptor-donor pattern (DAD), the latter being formed by donors and acceptors of hydrogen bridge linkages which comply with the β-sheet structure of the peptide or protein and thus fit as binding partners. The heterocyclic or aromatic agents are available at least as dimers. They recognise peptides and proteins with a β-sheet structure, form stable complexes with them and inhibit their aggregation to β-amyloid plaques. Furthermore, the new active agents are able to dissolve β-amyloid plaques that already exist. Another task of the current invention is to provide methods for the synthesis of said heterocyclic or aromatic compounds.

专利号:MD-4847-C1
优先权日:2021-09-09
标 题:Tris(2,6-dimethyl pyridinedicarboxylate-1kONO)-di-m-(isothiocyanato-1,2kN)-(diisothiocyanato-2kN)barium(II)cobalt(II) with the properties of a stimulator of the synthesis of biologically active substances in mushrooms

专利号:US-2003187271-A1
优先权日:2002-03-27
标题 :Synthesis of 2, 6-dicarbonylpyridines

专利号:WO-03082824-A1
优先权日:2002-03-27
标 题 :Synthesis of 2,6-dicarbonylpyridines

专利号:CN-106596542-A
优先权日:2016-12-20
标 题 :Synthesis of a UV Fluorescent Molecular Probe and Its Detection of Nitrite